ANALYSIS OF DRUG RELATED PROBLEM TO OUTPATIENT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN BALAI BESAR KESEHATAN PARU MASYARAKAT (BBKPM) BANDUNG

• Main Author: Mutia, Lisnawati
• Format: Final Project
• Language: Indonesia
• Online Access: https://digilib.itb.ac.id/gdl/view/45130
• Institution: Institut Teknologi Bandung

Chronic obstructive pulmonary disease (COPD) is a lung disease that can be prevented and treated, characterized by a persistent air flow resistance that is progressive nonreversible. The prevalence of COPD sufferers in Indonesia in 2013 was 3.7%. Meanwhile, according to WHO, in 2012 COPD occupies the 4 th leading cause of death in the world. COPD can not be cured, but with optimal management the symptoms can be controlled, slow the progression of the disease and improved quality of life of the patients. This study aimed to analyze the conformity of COPD management in Balai Besar Kesehatan Paru Masyarakat (BBKPM) Bandung with the standard treatment of the Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Update 2016 and analyze the drug related problems in patients with COPD. The study was conducted by analyzing data from medical records and interviewing. Patients included in this study were male patients aged > 45 years who were diagnosed with major COPD and / or without comorbidities for outpatient treatment at the Balai Besar Kesehatan Paru Masyarakat (BBKPM) Bandung from January to June 2016. The result from 106 patients showed that there are 16 cases (15,09%) of non-conformity with standard medical treatment GOLD. Then, the result of drug related problems (DRPs) medical records analyse showed that there are 15 cases (10,56%) of untreated indication, 53 cases (37,32%) without any indication of drugs, 25 cases (17,6%) overdoses, 29 cases (20,42%) underdose, 14 cases (9,86%) of drug interactions and 6 cases (4,22%) of adverse drug reactions. Total DRPs were 142 cases and experienced by 56 patients (52.83%), so it can be assumed that one patient have 3 types of DRPs. It is found from interviews that 7 patients (43.75%) made a mistake in the use of inhaled medications and 13 patients (81.25%) experience side effects due to drug use.